Veterinary Medicines

Avishield IB QX lyophilisate for oculonasal suspension/use in drinking water for chickens

Authorised
  • Avian infectious bronchitis virus, type QX, strain 1285, Live
Download as PDF

Product identification

Medicine name:
Avishield IB QX lyophilisate for oculonasal suspension/use in drinking water for chickens
Avishield IB QX liofilizat za okulonazalno suspenzijo/dajanje v vodo za pitje za piščance
Active substance:
  • Avian infectious bronchitis virus, type QX, strain 1285, Live
Target species:
  • Chicken
Route of administration:
  • Oculonasal use
  • In drinking water use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type QX, strain 1285, Live
    3.70
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken
      • Meat and offal
        0
        day
  • In drinking water use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:
  • Cardboard box with 10 vials of 1000 doses of vaccine
  • Cardboard box with 10 vials of 2500 doses of vaccine
  • Cardboard box with 10 vials of 5000 doses of vaccine

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 8 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Genera d.d.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • DC/V/0826/001
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0429/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Czechia
  • Denmark
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/09/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/09/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/09/2025
Download